Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus

• Prif Awduron: Giuseppe A. Ramirez (Awdur), Valentina Canti (Awdur), Stefania Del Rosso (Awdur), Roberta Erra (Awdur), Lucia Moiola (Awdur), Marco Magnoni (Awdur), Enrica P. Bozzolo (Awdur), Angelo A. Manfredi (Awdur), Patrizia Rovere-Querini (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Systemic lupus erythematosus (SLE) is associated with a constellation of complications affecting multiple organs, including neuropsychiatric manifestations (NPSLE) and ischaemic events, leading to increased long-term morbidity. Antiphospholipid antibodies (aPL) are a major determinant of...